systemic lupus erythematosus, mixed connective tissue disease, systemic sclerosis, rheumatoid arthritis, vasculitis syndrome, drug-induced lupus erytnematosus, healthy condition
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed or suspected having the target diseases in St. Marianna University hospital. Healthy individuals who visit St. Marianna University hospital (i.e., for medical check). Healthy individuals who work in St. Marianna University and St. Marianna University hospital.
Exclusion criteria
Exclusion criteria: Patients who are excluded from the entry by medical doctors (i.e., severe or moderate levels of anemia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Levels and post-translational modifications of U1-68k | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of protein expression and post-translational modification by drugs | — |
Countries
Japan
Contacts
St. Marianna University Graduate School of Medicice Disease Biomarker Analysis and Molecular Regulation